RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Papa Mze, Nasserdine ^a   Ndiaye, Yaye Die ^b   Diedhiou, Cyrille K ^a   Rahamatou, Silai ^c   Dieye, Baba ^b   Daniels, Rachel F ^d   Hamilton, Elizabeth J ^e   Diallo, Mouhamadou ^a   Bei, Amy K ^a,d   Wirth, Dyann F ^d,f   Mboup, Souleymane ^a   Volkman, Sarah K ^d,f,g   Ahouidi, Ambroise D ^a   Ndiaye, Daouda ^b  

^a Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c National Malaria Control Programme   (Comoros)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD UNIVERSITY   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g SIMMONS COLLEGE   (United States)

Author keywords

Comoros; dhfr; dhps; DNA source; Plasmodium falciparum; RDT; Senegal

Indexed keywords

GENOMIC DNA; MOLECULAR MARKER; PROTOZOAL DNA; PYRIMETHAMINE PLUS SULFADOXINE; PYROXYLIN; ANTIMALARIAL AGENT; DIAGNOSTIC KIT; PROTOZOAL PROTEIN;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CLONAL VARIATION; CODON; COMOROS; CONTROLLED STUDY; DHFR GENE; DHPS GENE; DNA EXTRACTION; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; MUTANT; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; RAPID TEST; SENEGAL; DIAGNOSTIC KIT; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HUMAN; MALARIA, FALCIPARUM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PARASITOLOGY;

ANTIMALARIALS; BASE SEQUENCE; COMOROS; DNA, PROTOZOAN; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; MUTATION; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREVALENCE; PROTOZOAN PROTEINS; REAGENT KITS, DIAGNOSTIC; SENEGAL;

EID: 84942435961     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0861-6     Document Type: Article

References (34)

1. World Malaria Report 2013. World Health Organization. 2013. http://www.who.int/malaria/publications/world-malaria-report-2013/.
2. Cnops L, Boderie M, Gillet P, Van Esbroeck M, Jacobs J. Rapid diagnostic tests as a source of DNA for Plasmodium species-specific real-time PCR. Malar J. 2011;10:67.
3. Ishengoma DS, Lwitiho S, Madebe RA, Nyagonde N, Persson O, Vestergaard LS, et al. Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence. Malar J. 2011;10:6.
4. Morris U, Aydin-Schmidt B, Shakely D, Martensson A, Jornhagen L, Ali AS, et al. Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria-assessment of DNA extraction methods and field applicability. Malar J. 2013;12:106.
5. Veron V, Carme B. Recovery and use of Plasmodium DNA from malaria rapid diagnostic tests. Am J Trop Med Hyg. 2006;74:941-3.
6. Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, et al. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 1996;348:1196-201.
7. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, et al. Averting a malaria disaster. Lancet. 1999;353:1965-7.
8. Yuthavong Y. Basis for antifolate action and resistance in malaria. Microbes Infect. 2002;4:175-82.
9. A-Elbasit IE, Khalil IF, Elbashir MI, Masuadi EM, Bygbjerg IC, Alifrangis M, et al. High frequency of Plasmodium falciparum CICNI/SGEAA and CVIET haplotypes without association with resistance to sulfadoxine/pyrimethamine and chloroquine combination in the Daraweesh area, in Sudan. Eur J Clin Microbiol Infect Dis. 2008;27:725-32.
10. Das S, Chakraborty SP, Hati A, Roy S. Malaria treatment failure with novel mutation in the Plasmodium falciparum dihydrofolatereductase (pfdhfr) gene in Kolkata, West Bengal, India. Int J Antimicrob Agents. 2013;41:447-51.
11. Mombo-Ngoma G, Oyakhirome S, Ord R, Gabor JJ, Greutélaers KC, Profanter K, et al. High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Malar J. 2011;10:123.
12. Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo. Trop Med Int Health. 2007;12:1164-71.
13. Wang P, Lee CS, Bayounmi R, Djimde A, Doumbo O, Swedberg G, et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroatesynthetase and dihydrofolatereductase alleles in a large number of field simples of diverse origins. Mol Biochem Parasitol. 1997;89:161-77.
14. Faye B, Ndiaye M, Ndiaye JL, Annie A, Tine RC, Lo AC, et al. Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal. Parasitol Res. 2011;109:133-8.
15. Henry M, Diallo I, Bordes J, Ka S, Pradines B, Diatta B, et al. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg. 2006;75:146-51.
16. Ndiaye D, Daily JP, Sarr O, Ndir O, Gaye O, Mboup S, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Trop Med Int Health. 2005;10:1176-9.
17. Ndiaye M, Tine R, Faye B, Ndiaye JL, Lo AC, Sylla K, et al. Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal. Am J Trop Med Hyg. 2013;88:1124-9.
18. Daniels R, Ndiaye D, Wall M, McKinney J, Séne PD, Sabeti PC, et al. Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2012;56:2976-86.
19. Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, et al. Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal. Int J Parasitol Drugs Drug Resist. 2013;3:135-42.
20. Rebaudet S, Bogreau H, Silaï R, Lepere JF, Bertaux L, Pradines B, et al. Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros Archipelago. Emerg Infect Dis. 2010;16:1686-94.
21. Randrianarivelojosia M, Raherinjafy RH, Migliani R, Mercereau-Puijalon O, Ariey F, Bedja SA. Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros. Parasite. 2004;11:419-23.
22. Tall A, Rabarijaona LP, Robert V, Bedja SA, Ariey F, Randrianarivelojosia M. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union. Acta Trop. 2007;102:176-81.
23. Mouchet J, Carnevale P, Coosemans M, Julvez J, Manguin S, Richard-Lenoble D, et al. Biodiversité du paludisme dans le monde. Paris: John Libbey Eurotext; 2004.
24. Ndiaye D, Patel V, Demas A, LeRoux M, Ndir O, Mboup S, et al. A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials-increased sensitivity of P. falciparum to chloroquine in Senegal. Am J Trop Med Hyg. 2010;82:228-30.
25. Snounou G, Zhu X, Spiripoon N, Jarra W, Thaithong S, Brown KN, et al. Biased distribution of msp1 and msp2 allelic variant in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg. 1999;93:369-74.
26. Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, et al. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France, 2004-2007. Am J Trop Med Hyg. 2007;77:431-7.
27. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, Radrianjafy R, et al. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother. 2009;53:4588-97.
28. RPP. Revue de la Performance du Paludisme dans l'union des Comores, rapport non publié; 2011.
29. Anglaret X. Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa. Lancet. 2001;358:1027-8.
30. Whitty CJ, Jaffar S. Plasmodium falciparum cross resistance. Lancet. 2002;359:80.
31. Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, et al. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Uganda children with uncomplicated falciparum malaria. Infect Genet Evol. 2004;4:321-7.
32. McCollum AM, Schneider KA, Griffing SM, Zhou Z, Kariuki S, ter-Kuile F, et al. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya. Malar J. 2012;11:77.
33. World Health Organization. Report of the technical consultation on intermittent preventive treatment in infants (IPTi), technical expert group on preventive chemotherapy. Geneva: World Health Organization; 2009. p. 1-11.
34. WHO. Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum Malaria control in Africa. Geneva: World Health Organization; 2010.